Skip to main content
Veterinary Medicines

Rogiola 5 mg chewable tablets for dogs

Authorised
  • Robenacoxib

Product identification

Medicine name:
Rogiola 5 mg chewable tablets for dogs
Rogiola Vet. 5 mg tyggetabletter
Active substance:
  • Robenacoxib
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Robenacoxib
    5.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Chewable tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AH91
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Available in:
  • Denmark
Package description:
  • OPA/Al/PVC/Aluminium perforated blister containing 10 tablets: 10 x 1 chewable tablet in perforated unit dose blisters, in a cardboard box.
  • OPA/Al/PVC/Aluminium perforated blister containing 10 tablets: 30 x 1 chewable tablet in perforated unit dose blisters, in a cardboard box.
  • OPA/Al/PVC/Aluminium perforated blister containing 10 tablets: 60 x 1 chewable tablet in perforated unit dose blisters, in a cardboard box.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • TAD Pharma GmbH
  • Krka-Farma d.o.o.
  • KRKA tovarna zdravil d.d. Novo mesto
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 69825
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0785/001
Concerned member states:
  • Austria
  • Belgium
  • Cyprus
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Italy
  • Netherlands
  • Norway
  • Portugal
  • Spain
  • Sweden

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
Danish (, TYGGETABLETTER 5 MG)
Published on: 6/06/2024